values of 8.6 µm and 10 µm, respectively. The postlysosomal metabolism of cholesterol to CE in macrophages was also inhibited by the compound with a similar IC 50 value of 13.2 µm. However, the compound exhibited almost no effect on acylCoA : cholesterol acyltransferase, a key enzyme in CE syn thesis localized in the endoplasmic reticulum (ER). From the fluorescent microscopic observation of cellular lipids, bufalintreated macrophages increased the accumulation of free cholesterol in lysosomes and caused to enlarge the shape and volume of lysosomes as well as pregnenolone-treated macrophages. These findings suggest that bufalin inhibited the postlysosomal metabolism of cholesterol, leading to a reduction of lipid droplets in mouse macrophages without cytotoxicity.
In the early stage of atherosclerosis, macrophages penetrate into the intima, efficiently take up modified low-density lipoprotein (LDL), store cholesterol and fatty acid as the respective forms of cholesteryl ester (CE) and triacylglycerol (TG) in cytosolic lipid droplets, and are converted to foam cells, leading to the development of atherosclerosis in the arterial wall. Therefore, inhibitors of lipid droplet accumulation in macrophages would be expected to retard the progression of atherosclerosis.
1-4)
We have established a cell-based assay for lipid droplet synthesis using mouse macrophages. 5) During the course of our screening program, microbial metabolites of beauveriolides, [6] [7] [8] [9] phenochalasins, 10, 11) spylidone, 12) sespendole, 13) isobisvertinol, 14) quinadoline B, 15) pentacecilide 16) and K97-0239 17) were found to be inhibitors of lipid droplet accumulation in macrophages, and some inhibitors were investigated in terms of inhibition of the mechanism of action of lipid droplet accumulation in macrophages. 18, 19) From further screening studies, bufalin, a known cardiotonic steroid from Chinese toad 20) (Fig. 1) , was found to possess such activity. Bufalin is one of the major components of the Chinese medicine Chan'su, which is given in small dosages for stimulation of myocardial contraction and also for treatment of tonsillitis, sore throat and palpitation. 20, 21) Here, we show that bufalin inhibits CE synthesis by inducing the accumulation of endocytosed free cholesterol in lysosomes to block further cholesterol metabolism, leading to inhibit the accumulation of lipid droplets in macrophages. 
MATERIALS AND METHODS

Materials
.). [1-
14 C] Oleoyl-CoA (1.85 GBq/mmol) was purchased from GE Healthcare (Buckinghamshire, England). Dulbecco's modified Eagle's medium (DMEM) and Hank's buffered salt solution (HBSS) were purchased from Nissui Pharmaceutical Co. (Tokyo, Japan), GIT medium was from Nippon Seiyaku Co. (Tokyo, Japan), and penicillin (10000 units/mL), streptomycin (10000 mg/mL), glutamine (200 mm) solution, alamar Blue™ and LysoTracker Red were from Invitrogen (Carlsbad, CA, U.S.A.). Phosphatidylcholine, phosphatidylserine, dicetylphosphate, cholesterol, filipin III and 3β-hydroxy-5-pregnen-20-one (pregnenolone) were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.).
Assay for Lipid Droplet Accumulation in Mouse Macro phages The assay for lipid droplet accumulation in mouse peritoneal macrophages was carried out according to a previously described method. 5) In brief, primary mouse peritoneal macrophages (5×10 5 cells in GIT medium) in each well of * To whom correspondence should be addressed. e-mail: tomodah@pharm.kitasato-u.ac.jp an 8-well glass chamber slide (Nalge Nunc International K.K., Rochester, NY, U.S.A.) were incubated in a humidified CO 2 (5% v/v) atmosphere at 37°C for 2 h. The medium was then replaced with 0.25 mL of DMEM containing 8% (v/v) lipoprotein-deficient serum (LPDS), penicillin (100 units/mL) and streptomycin (100 mg/mL) (hereafter referred to as medium A). After another 2-h preincubation, a sample (2.5 µL in methanol solution) and liposomes (10.0 µL, 1.0 µmol phosphatidylcholine, 1.0 µmol phosphatidylserine, 0.20 µmol dicetylphosphate and 1.5 µmol cholesterol, suspended in 1.0 mL of 0.3 m glucose) were added to each well. After 14-h incubation, the cells were washed with phosphate-buffered saline (PBS) and then fixed by soaking in 10% formalin. Nuclei and intracellular neutral lipid droplets were then stained with hematoxylin and oil red O, respectively. The lipid droplet formation and morphological changes in macrophages were examined by confocal-laser scanning microscopy (LSM-510 META, Carl Zeiss, Oberkochen, Germany).
Assay . Following 14-h incubation, the medium was removed and the cells in each well were washed three times with PBS. The cells were lysed by adding 0.25 mL of PBS containing 0.1% (w/v) sodium dodecyl sulfate (SDS), and the cellular lipids were extracted by the method of Bligh and Dyer. 22) After concentrating the organic solvent, the total lipids were separated on a TLC plate (silica gel F254, 0.5 mm thick, Merck, Darmstadt, Germany) and analyzed with a FLA-7000 (FUJIFILM, Tokyo, Japan).
Cytotoxicity of Bufalin to Mouse Macrophages
The cytotoxicity of bufalin to mouse macrophages after 14-h incubation was measured using alamar blue reagent according to the established method.
9)
Assay for Cholesteryl Ester Synthesis in Mouse Macro phages The assay for the synthesis of [
14 C] CE from [ 14 C]-cholesterol in mouse macrophages was carried out according to a previously described method. 5, 9) In brief, mouse peritoneal macrophages (5×10 5 cells-0.25 mL of medium A) were cultured in each well of a 48-well plastic microplate, and then a test compound (2.5 µL in methanol solution) and liposomes (10 µL) containing [
14 C] cholesterol (7.4 kBq) were added to each culture. Following 14-h incubation, cellular lipids were extracted to measure the radioactivity of [
14 C] cholesterol and [ 14 C] CE according to the same method as described above.
Assay for Lysosomal Cholesterol Metabolism in Mouse Macrophages
The metabolism of lysosomal [
14 C] cholesterol in mouse macrophages was measured as described previously. 9, 23) Briefly, mouse peritoneal macrophages (5×10 5 cells) were incubated for 2 h in a 48-well plastic microplate, washed with HBSS and placed in 0.25 mL of medium A containing liposomes (10 µL) with [
14 C] cholesterol (7.4 kBq) and pregnenolone (2.5 µL in methanol solution to make a final concentration of 10 µm). After incubation for 14 h, the medium was removed, and the cells were washed twice with buffer A (150 mm NaCl and 50 mm Tris-HCl, pH 7.4) containing bovine serum albumin (BSA) (2.0 mg/mL), washed again with buffer A and subsequently incubated in 0.25 mL of medium A containing bufalin (2.5 µL in methanol solution). After 10-h incubation, cellular lipids were extracted to measure [
Preparation of the Microsomes from Macrophages
The microsomes of mouse peritoneal macrophages were prepared according to a method described previously. 9) Briefly, mouse peritoneal macrophages (2×10 8 cells) were homogenized in 3.0 mL of cold buffered sucrose solution (pH 7.2) containing 100 mm sucrose, 50 mm KCl, 40 mm KH 2 PO 4 and 30 mm ethylenediamine-N,N,N′,N′-tetraacetic acid (EDTA) (hereafter referred to as Buffer B) in a Teflon homogenizer. The microsomes were pelleted by centrifugation at 100000×g for 1 h at 4°C, resuspended in the same buffer at a concentration of 5 mg of protein/mL and stored at −80°C until use.
Assay for ACAT Activity in Microsomes Prepared from Mouse Macrophages Acyl-CoA : cholesterol acyltransferase (ACAT) was determined using the isotope method as described previously. 9) Briefly, an assay mixture containing 2.5 mg/mL BSA in Buffer B and [
14 C] oleoyl-CoA (18.5 kBq) together with a test compound (added as 10 µL of a methanol solution to make a final concentration of 0-325 µm), and the microsomes (100 µg of protein) in a total volume of 200 µL were incubated at 37°C for 5 min. The reaction was stopped by adding 1.2 mL of chloroform-methanol (2 : 1), and the product [ 14 C] CE was extracted and measured according to the same method as described above.
Staining of Free Cholesterol and Lysosomes in Macro phages
Mouse peritoneal macrophages (5×10 5 cells-0.25 mL of medium A) were incubated for 2 h in an 8-well glass chamberslide, and then test compounds (2.5 µL in methanol solution) and liposomes (10 µL) were added to each culture. Following 14-h incubation, 75 nm LysoTracker was added according to the manufacturer's instructions. After a further 2-h incubation, the cells were washed with PBS and then fixed by soaking in 10% formalin. After the cells were washed with PBS containing 1.5 mg/mL glycine, free cholesterol was stained with 50 µg/mL filipin for 2 h and mounted with Prolong Antifade reagent (Invitrogen) according to the manufacturer's instructions. The localization of lysosomes and free cholesterol in macrophages was examined by confocallaser scanning microscopy (LSM-510 META). Fluorescence of LysoTracker and filipin was determined at wavelengths of 543 and 364 nm, respectively. Care was taken to ensure that the detection sensitivity was kept constant. Composite figures were prepared using Photoshop CS2 (Adobe Systems, San Jose, CA, U.S.A.).
RESULTS
Inhibition of Lipid Droplet Accumulation in Mouse
Macrophages by Bufalin In this macrophage assay, significant amounts of lipid droplets accumulated in the cytosol, as observed microscopically after oil red O staining, when the macrophages were incubated with liposomes. Under these conditions, bufalin was found to dose-dependently inhibit lipid droplet accumulation. Significant inhibition was observed at 24 µm and 120 µm (Fig. 2) .
Inhibition of Cholesteryl Ester Synthesis in Mouse Mac rophages by Bufalin
Under the conditions of lipid droplet accumulation in mouse macrophages, about 40% of exogenously added [ 14 C] oleic acid was incorporated into the neutral lipids [
14 C] CE and [ 14 C] TG, which are the main constituents of lipid droplets in the cytosol. 5) As shown in Fig. 3A , bufalin showed rather selective inhibition of CE synthesis (IC 50 : 8.6 µm) compared with that of TG synthesis (IC 50 : 103 µm), and showed no cytotoxic effect even at the highest dose (120 µm). These biochemical data are comparable with the morphological data (Fig. 2) (Fig. 3B) . Conversely, unesterified free [
14 C] cholesterol levels in the cells increased by 1.3-to 1.5-fold in the presence of 24-120 µm bufalin (data not shown). 
Inhibition of Postlysosomal Cholesterol Metabolism in
Fig. 3. Inhibition of Cholesteryl Ester Synthesis in Macrophages by Bufalin
Mouse Macrophages by Bufalin To obtain some insight regarding the target molecule of bufalin in the inhibition of lipid droplet accumulation in macrophages, the effect of bufalin on the postlysosomal process of cholesterol metabolism was studied using pregnenolone, a well-known inhibitor of cellular cholesterol transport. 24 (Figs. 3A, B) . These data indicate that bufalin blocks the postlysosomal processes of cholesterol metabolism.
Effect of Bufalin on ACAT Activity The experiment described above using pregnenolone indicated that the inhibition site of bufalin lies within the steps between the exit of cholesterol from the lysosomes and cholesterol esterification in the endoplasmic reticulum (ER). Therefore, the effect of bufalin on ACAT activity was evaluated using microsomes prepared from mouse macrophages. However, bufalin showed very weak inhibitory activity against ACAT with an IC 50 value over ten times higher (IC 50 : 110 µm, data not shown) than those of CE synthesis from [
14 C] oleic acid and [ 14 C] cholesterol (IC 50 : 8.6, 10 µm, respectively) in the macrophages, indicating that its molecular target in macrophages is not ACAT.
Colocalization of Free Cholesterol and Lysosomes in BufalinTreated Macrophages
Bufalin showed almost no effect on ACAT activity. Thus, we compared the effect of bufalin on cholesterol metabolism in macrophages with that of pregnenolone because bufalin and pregnenolone have a common steroid-like backbone structure. Therefore, mouse macrophages were treated with bufalin (24 µm) or pregnenolone (10 µm) under the conditions of lipid drop accumulation, and lysosomes and free cholesterol were labeled by LysoTracker (acidic organelle probe) 25) and filipin (bound to free cholesterol), 26) respectively. From observation by confocal-laser scanning microscopy, in the drug-untreated macrophages, a small amount of free cholesterol was detected and colocalized with lysosomes (Control in Fig. 4) . Most cholesterol was accumulated as CE in lipid droplets in druguntreated macrophages. On the other hand, a large amount of free cholesterol was accumulated in the bufalin-treated macrophages, which was colocalized in lysosomes (Fig. 4, middle) . And the shape and volume of lysosomes in bufalin-treated macrophages were enlarged (Fig. 4, middle) . In the pregnenolone-treated macrophages, a large amount of free cholesterol was colocalized in lysosomes, and the shape and volume of lysosomes were enlarged (Fig. 4, lower) . These findings indicated that these drug-treated macrophages showed very similar cholesterol colocalization and similar shape of lysosomes. When mouse macrophages treated 10 µm pregnenolone were incubated with [ 
23)
DISCUSSION
Bufalin, a component of the Chinese medicine Chan'su, 20) was found to inhibit lipid droplet accumulation in mouse macrophages (Fig. 2) . Bufalin selectively inhibited CE synthesis from oleic acid or cholesterol in macrophages without cytotoxicity (Figs. 3A, B) , and the point of inhibition was between the exit of cholesterol from lysosomes and cholesterol esterification in the ER (Fig. 3C) . However, bufalin showed almost no inhibitory effect on ACAT localized in ER membrane. Therefore, to determine the effect on the cholesterol metabolism in macrophages, these macrophages were investigated by fluorescent microscopy, compared with the inhibitory effect on lipid droplet accumulation by pregnenolone, an inhibitor of cholesterol transport from lysosomes (Fig. 4) . Bufalin caused accumulation of free cholesterol in lysosomes as well as pregnenolone. 23 ) Therefore, we concluded that bufalin inhibits lipid droplet accumulation by accumulating free cholesterol in lysosomes to block further metabolism of free cholesterol in mouse macrophages. These might be several possibilities to explain the mechanism; One potential mechanism is that bufalin blocks the transport of free cholesterol from lysosomes to ER as well as pregnenolone as reported previously.
23) However, as the shape and volume of lysosomes in bufalin-and pregnenolone-treated macrophages were found to change (enlarge) significantly, the function of lysosomes might be partially damaged to block the free cholesterol metabolism from lysosomes.
Certain steroids were shown to inhibit lipid drop accumulation in mouse macrophages. 27, 28) Two kinds of inhibition site were reported. Aikawa et al. reported that steroids having an oxo group at the C17 or C20 position, such as pregnenolone, androstenedione, dehydroisoandrosterone and progesterone, inhibit CE accumulation in macrophages by blocking the intracellular transport of endocytosed cholesterol from the lysosomes to the ER. 24) On the other hand, other steroids, such as epi-cochlioquinone and (20R)-protopanaxadiol, inhibit ACAT activity. 29, 30) In this study, we demonstrated that bufalin, a different type of steroid having a delta lactone ring at the C17 position, also inhibits postlysosomal cholesterol metabolism and leads to reduction of lipid droplets in mouse macrophages.
Bufalin is a well-known inhibitor of Na + /K + ATPase and has been clinically used in traditional Chinese medicine to treat cardiotonic diseases. 20, 21, 31) Furthermore, bufalin induces apoptosis in human leukemia cells. 32, 33) In this study, bufalin was found to show a new biological activity: inhibition of lipid droplet accumulation and CE synthesis in mouse macrophages. Thus, bufalin is also expected to be a useful tool for studying cellular cholesterol metabolism.
